Mallinckrodt Pharmaceuticals
MNK
$0.34
Share price
0.00%
Change (1 day)
-94.06%
Change (1 year)
Categories
Earnings for Mallinckrodt Pharmaceuticals (MNK)
Earnings in 2023 (TTM): -$1.16 B
According to Mallinckrodt Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are -$1.16 B. In 2022 the company made an earning of -$1.47 B a decrease over its 2021 earnings that were of -$0.83 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Mallinckrodt Pharmaceuticals from 2013 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$1.16 B | -21.31% |
| 2022 | -$1.47 B | 76.14% |
| 2021 | -$0.83 B | -13.63% |
| 2020 | -$0.97 B | -39.63% |
| 2019 | -$1.6 B | -61.51% |
| 2018 | -$4.14 B | -6812.18% |
| 2017 | $61.6 M | -185.79% |
| 2016 | -$71.8 M | -131.27% |
| 2015 | $0.22 B | -166.82% |
| 2014 | -$0.35 B | -319.69% |
| 2013 | $0.15 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $16.97 B | -1,575.70% | 🇺🇸 USA |
 General Electric GE | $11.30 B | -1,083.31% | 🇺🇸 USA |
 Zogenix ZGNX | -$0.22 B | -81.56% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $0.40 B | -135.21% | 🇮🇱 Israel |